---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-034075"
form_type: "8-K"
ticker: "SSKN"
cik: "0001051514"
company_name: "STRATA Skin Sciences, Inc."
filed_at: "2023-07-11T23:59:59+00:00"
generated_at: "2026-06-13T09:46:25.458238+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Strata Skin Sciences announces JCAD publication highlighting TheraClearX for acne treatment

## Summary
- Journal of Clinical and Aesthetic Dermatology published review and expert article on TheraClearX for mild-to-moderate acne vulgaris.
- Article highlights visible improvement as early as second treatment, no downtime, and customization for all Fitzpatrick skin types.
- CEO Bob Moccia stated the publication expands on device's safety, efficacy, and integration into practice.
- Dr. Gilly Munavalli, author, noted TheraClearX is effective non-pharmaceutical acne treatment with little downtime.

## SEC filing metadata
- accession: 0001140361-23-034075
- form_type: 8-K
- ticker: SSKN
- cik: 0001051514
- company_name: STRATA Skin Sciences, Inc.
- filed_at: 2023-07-11T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1051514/000114036123034075/0001140361-23-034075-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1051514/000114036123034075/brhc20055766_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-034075
- JSON: https://secwatch.observer/filing/0001140361-23-034075.json
- Plain text: https://secwatch.observer/filing/0001140361-23-034075.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.